Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 Msec

NCT00879242 ·Status: COMPLETED ·Phase: PHASE2

A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis

NCT00171171 ·Status: COMPLETED ·Phase: PHASE3

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload

NCT00600938 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH)

NCT03203850 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of Deferasirox in Combination With Desferoxamine in β-thalassaemia Patients With Severe Cardiac Iron Overload

NCT01459718 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia

NCT01709838 ·Status: COMPLETED ·Phase: PHASE4

Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses

NCT01948817 ·Status: WITHDRAWN ·Phase: PHASE2

Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome

NCT01892644 ·Status: WITHDRAWN ·Phase: PHASE2

Retrospective Evaluation of Adult and Pediatric Transfusion-dependent Patients Treated With Deferasirox Therapy

NCT01874405 ·Status: COMPLETED

Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis

NCT00395629 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload

NCT01254227 ·Status: COMPLETED ·Phase: PHASE2

Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients

NCT00110266 ·Status: COMPLETED ·Phase: PHASE2

Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients

NCT00350662 ·Status: COMPLETED ·Phase: PHASE3

A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload

NCT00171821 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).

NCT01090323 ·Status: COMPLETED ·Phase: PHASE2

Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients

NCT00303329 ·Status: COMPLETED ·Phase: PHASE2

Post Hematopoietic Stem Cell Transplantation

NCT01610297 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis

NCT00000595 ·Status: COMPLETED ·Phase: PHASE2

Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload

NCT00235391 ·Status: COMPLETED ·Phase: PHASE3

Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)

NCT02125877 ·Status: COMPLETED ·Phase: PHASE2

Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet

NCT02993224 ·Status: COMPLETED ·Phase: PHASE2

This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.

NCT01250951 ·Status: COMPLETED ·Phase: PHASE4

Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia

NCT00069862 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload

NCT01511848 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients

NCT00349453 ·Status: COMPLETED ·Phase: PHASE2